Fri, June 2, 2023
Thu, June 1, 2023
Wed, May 31, 2023
Tue, May 30, 2023
Mon, May 29, 2023
Sun, May 28, 2023
Fri, May 26, 2023

Andrew Fein Reiterated (AMLX) at Strong Buy and Held Target at $50 on, May 31st, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-50-on-may-31st-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Andrew Fein of HC Wainwright & Co., Reiterated "Amylyx Pharmaceuticals, Inc." (AMLX) at Strong Buy and Held Target at $50 on, May 31st, 2023.

Andrew has made no other calls on AMLX in the last 4 months.



There are 3 other peers that have a rating on AMLX. Out of the 3 peers that are also analyzing AMLX, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Chris Shibutani of "Goldman Sachs" Maintained at Hold with Increased Target to $47 on, Tuesday, March 14th, 2023


These are the ratings of the 2 analyists that currently disagree with Andrew


  • Graig Suvannavejh of "Mizuho" Maintained at Strong Buy with Decreased Target to $50 on, Monday, May 15th, 2023
  • Itay Michaeli of "Citigroup" Maintained at Strong Buy with Increased Target to $54 on, Tuesday, March 14th, 2023

Publication Contributing Sources